TRAPEASE® Permanent Vena Cava Filter
In PE cases that require permanent placement of an IVC filter, the TRAPEASE® Vena Cava Filter offers a solution proven with design strength.
The TRAPEASE® Filter is indicated for the prevention of recurrent pulmonary embolism via percutaneous placement in the inferior vena cava in the following situations:
Pulmonary thromboembolism when anticoagulants are contraindicated.
Failure of anticoagulant therapy in thromboembolic diseases.
Emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced.
Chronic, recurrent pulmonary embolism where anticoagulant therapy has failed or is contraindicated. The Angiographic Vessel Dilator is designed to provide angiographic visualization and linear measurement of the vasculature when combined with the delivery of radiopaque contrast media to the vena cava.
The TRAPEASE® Filter should not be implanted in:
Patients with risk of septic embolism.
Patients with uncontrolled infectious disease.
Patients with an IVC diameter larger than 30 mm.
Patients contraindicated for procedures under fluoroscopy
Patients with demonstrated hypersensitivity to one of the components of the TRAPEASE® Filter. There are no known contraindications for use of the Angiographic Vessel Dilator.